Sage Journals: Discover world-class research

Open access

Research article

First published 2024-10

Antifibrotic drug treatment of patients with idiopathic pulmonary fibrosis in Sweden: A registry-based observational study

Lisa Carlson, Dimitrios Kalafatis, Ida Pesonen [...]

Chronic Respiratory Disease

Open access

Review article

First published 2022

The role of antifibrotics in the treatment of rheumatoid arthritis–associated interstitial lung disease

Minrui Liang, Eric L. Matteson, Andy Abril [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Review article

First published 2022

The role of antifibrotic therapies in the treatment of systemic sclerosis–associated interstitial lung disease

Gonçalo Boleto, Jérôme Avouac, Yannick Allanore

Therapeutic Advances in Musculoskeletal Disease

Retricted access

Research article

First published 2025-01

In Sequence Antifibrotic Treatment and Rehabilitation after Volumetric Muscle Loss Injury

Peter R. Nicholson, Christiana J. Raymond-Pope, Thomas J. Lillquist [...]

Advances in Wound Care

Open access

Research article

First published 2024

Real-world antifibrotic treatment patterns in patients with idiopathic pulmonary fibrosis: retrospective analyses of two large healthcare administrative databases in the United States

Ying Qiu, Julia Zhu, Pooja Chopra [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2022

Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter,prospective survey from Poland

Katarzyna Górska, Marta Maskey-Warzęchowska, Małgorzata Barnaś [...]

Sage Open Chronic Disease

Open access

Research article

First published 2019

Medication persistence rates and predictive factors for discontinuation of antifibrotic agents in patients with idiopathic pulmonary fibrosis: a real-world observational study

Keiji Oishi, Tsunahiko Hirano, Yoriyuki Murata [...]

Therapeutic Advances in Respiratory Disease

Free access

Research article

First published 2021

DSP rs2076295 variants influence nintedanib and pirfenidone outcomes in idiopathic pulmonary fibrosis: a pilot study

Martina Doubkova, Eva Kriegova, Simona Littnerova [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2019

Physician characteristics associated with treatment initiation patterns in idiopathic pulmonary fibrosis

Peter P LaCamera, Susan L Limb, Tmirah Haselkorn [...]

Chronic Respiratory Disease

Open access

Review article

First published 2021

Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease

Erin M. Wilfong, Rohit Aggarwal

Therapeutic Advances in Musculoskeletal Disease

Search results